JP2023541007A5 - - Google Patents
Info
- Publication number
- JP2023541007A5 JP2023541007A5 JP2023515155A JP2023515155A JP2023541007A5 JP 2023541007 A5 JP2023541007 A5 JP 2023541007A5 JP 2023515155 A JP2023515155 A JP 2023515155A JP 2023515155 A JP2023515155 A JP 2023515155A JP 2023541007 A5 JP2023541007 A5 JP 2023541007A5
- Authority
- JP
- Japan
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063074602P | 2020-09-04 | 2020-09-04 | |
| US63/074,602 | 2020-09-04 | ||
| US202163142669P | 2021-01-28 | 2021-01-28 | |
| US63/142,669 | 2021-01-28 | ||
| PCT/US2021/048991 WO2022051575A2 (en) | 2020-09-04 | 2021-09-03 | Compounds and methods for treating viral infection |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023541007A JP2023541007A (ja) | 2023-09-27 |
| JPWO2022051575A5 JPWO2022051575A5 (https=) | 2024-09-12 |
| JP2023541007A5 true JP2023541007A5 (https=) | 2024-09-12 |
Family
ID=80491477
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2023515155A Pending JP2023541007A (ja) | 2020-09-04 | 2021-09-03 | ウイルス感染処置のための化合物および方法 |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20230346816A1 (https=) |
| EP (1) | EP4208137A4 (https=) |
| JP (1) | JP2023541007A (https=) |
| CA (1) | CA3194024A1 (https=) |
| MX (1) | MX2023002667A (https=) |
| TW (1) | TW202228730A (https=) |
| WO (1) | WO2022051575A2 (https=) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TW202239417A (zh) * | 2021-01-29 | 2022-10-16 | 艾米爾 Ｅ 哈森 | 預防病毒感染之方法 |
| CA3256512A1 (en) * | 2022-04-21 | 2023-10-26 | Therapeutikos, Inc. | METHODS OF TREATING INFLAMMATION |
| GB2628963A (en) * | 2023-02-08 | 2024-10-16 | Univ Of Lincoln | Formulations and uses thereof |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1533776A (zh) * | 2003-03-27 | 2004-10-06 | 中国人民解放军第三军医大学 | N-乙酰氨基葡萄糖在制备用于治疗病毒或细菌感染所致的局部损伤和全身症状的药物中的应用 |
| AU2006249771A1 (en) * | 2005-05-24 | 2006-11-30 | Wellgen, Inc. | Compositions and methods for the prevention and treatment of conditions associated with inflammation |
| WO2011046057A1 (ja) * | 2009-10-15 | 2011-04-21 | 独立行政法人産業技術総合研究所 | シアリルラクトサミン系、シアリルルイスx系のシアル酸とフコース含有新規糖鎖化合物 |
| JP5807895B2 (ja) * | 2011-02-17 | 2015-11-10 | 学校法人慶應義塾 | Ｈｃｖｒｎａ複製抑制剤 |
| NZ732118A (en) * | 2011-04-15 | 2018-11-30 | Marine Polymer Tech Inc | Treatment of disease with poly-n-acetylglucosamine nanofibers |
| CN107281199A (zh) * | 2017-07-27 | 2017-10-24 | 吉林省始祖生物波医学研究院有限公司 | N‑乙酰‑d‑氨基葡萄糖及其药物可接受盐在制备治疗病毒性肝炎药物中的应用及药物 |
-
2021
- 2021-09-03 TW TW110132929A patent/TW202228730A/zh unknown
- 2021-09-03 MX MX2023002667A patent/MX2023002667A/es unknown
- 2021-09-03 US US18/024,399 patent/US20230346816A1/en active Pending
- 2021-09-03 CA CA3194024A patent/CA3194024A1/en active Pending
- 2021-09-03 JP JP2023515155A patent/JP2023541007A/ja active Pending
- 2021-09-03 EP EP21865159.4A patent/EP4208137A4/en active Pending
- 2021-09-03 WO PCT/US2021/048991 patent/WO2022051575A2/en not_active Ceased